This site has been optimized to work with modern browsers and does not fully support your version of Internet Explorer.


Oxford University Hospitals NHS Foundation Trust and Oxford University, in partnership, have an international reputation for research excellence. Patients benefit from world-class discovery and innovation and a growing portfolio of studies addressing major conditions including cancer, dementia and stroke.

Oxford is a National Institute for Health Research Biomedical Research Centre, an Experimental Cancer Medicine Centre and a CRUK Major Cancer Centre. Oxford University Hospitals NHS Foundation Trust is the host NHS Trust for the Oxford Academic Health Science Network – one of 15 AHSNs across England and an Academic Health Science Centre.

Opportunities for research are extensive and often involve novel collaborations with research groups outside of medicine, such as engineers.

Oxford has been recently designated as one of 11 Genomic Medicine Centres as part of the 100,000 Genomes Project main programme. This provides numerous opportunities for working with whole genome sequence data in both diagnostics and research.  Oxford University Hospitals is home to the Oxford Molecular Diagnostics Centre (MDC), headed by Professor Anna Schuh, which is a fully CPA-accredited NHS laboratory that comprises the Oxford Regional Genetics Laboratory (ORGL), the Molecular Pathology and Haematology Laboratory, a clinical Next Generation Sequencing (NGS) core facility and the Oxford GEL BioRepository.  Heads of Bioinformatics and Clinical Informatics are responsible for the analysis of NGS data and aggregation of phenotypic data respectively. The MDC receives referrals from NHS, industry, clinical trials and research groups. It comprises a BRC funded R&D unit to develop, innovate, validate and evaluate clinical utility of genomics.

The NHS Cellular Pathology department at the John Radcliffe Hospital, Oxford has close links with several university departments, including the Nuffield Department of Clinical Laboratory Sciences, headed by Professor Alison Banham, and the Nuffield Department of Surgical Sciences, headed by Professor Freddie Hamdy.

Research and training

Trainees within the region are encouraged to participate in research and audit during their training, and there are ample opportunities to do so. In addition, there are several academic training posts currently in the region, the academic component of which is based at the John Radcliffe Hospital. These posts are additionally supported by the Oxford University Clinical Academic Graduate School (OUCAGS).


Copyright 2021 © Thames Valley Cellular Pathology